Impact of decreasing copayments on medication adherence within a disease management environment

Health Affairs
Michael E ChernewA Mark Fendrick

Abstract

This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.

References

May 20, 2004·JAMA : the Journal of the American Medical Association·Dana P GoldmanSteven M Teutsch
Oct 28, 2004·Health Affairs·Sandra M Foote
Mar 4, 2006·Pharmacoepidemiology and Drug Safety·Susan E AndradeK Arnold Chan
Feb 1, 2007·Health Affairs·Michael E ChernewA Mark Fendrick
Jul 5, 2007·JAMA : the Journal of the American Medical Association·Dana P GoldmanYuhui Zheng

❮ Previous
Next ❯

Citations

Jan 9, 2010·Journal of General Internal Medicine·Michael ChernewA Mark Fendrick
May 11, 2012·Journal of General Internal Medicine·Mitesh S PatelMonica L Lypson
Jun 14, 2012·Journal of General Internal Medicine·Anders Chen, Craig Evan Pollack
Feb 20, 2010·Healthcare Management Forum·Francois DionneMorris Barer
Nov 15, 2011·The New England Journal of Medicine·Niteesh K ChoudhryUNKNOWN Post-Myocardial Infarction Free Rx Event and Economic Evaluation (MI FREEE) Trial
Oct 1, 2010·Population Health Management·Kavita V NairVinita Biddle
Nov 19, 2011·Population Health Management·Joshua CohenLanna Feldman
Jul 25, 2012·Population Health Management·Alyssa B SchultzDee W Edington
Feb 15, 2013·Population Health Management·Daniel J ElliottPaula L Stillman
Nov 4, 2008·Annual Review of Public Health·Dahlia K Remler, Jessica Greene
Oct 12, 2010·Digestive Diseases·Peter D R Higgins
Apr 9, 2009·Implementation Science : IS·Alicen SpauldingAllison B Rosen
Oct 1, 2011·National Bureau of Economic Research Bulletin on Aging and Health
May 21, 2011·The Journal of Economic Perspectives : a Journal of the American Economic Association·Katherine Baicker, Dana Goldman
May 15, 2010·American Journal of Health Promotion : AJHP·Jean P HallJanice M Moore
Feb 2, 2013·Preventing Chronic Disease·O Kenrik DuruSusan Ettner
Jul 23, 2013·Population Health Management·Susan E HagenDee W Edington
Oct 24, 2013·Cardiovascular Drugs and Therapy·Steven Simoens, Peter R Sinnaeve
Oct 25, 2013·Population Health Management·Bruce G Bender
Aug 22, 2009·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Kevin D Frick, Michael E Chernew
Dec 20, 2012·Current Cardiology Reports·Nihar R Desai, Niteesh K Choudhry
Sep 8, 2009·Current Medical Research and Opinion·Eve J HigginbothamAngela Guckian
Sep 10, 2015·The American Journal of the Medical Sciences·Cathleen M RiveraDaniel J MacCarthy
Sep 3, 2011·American Heart Journal·Hayden B BosworthChristopher B Granger
Jun 18, 2011·Academic Radiology·Aine Marie Kelly, Paul Cronin
Apr 26, 2011·Seminars in Oncology Nursing·Sandra L SpoelstraMarcia Grant
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·William B Stason
Oct 29, 2008·Journal of the American College of Radiology : JACR·Aine Marie KellyRuth C Carlos
Feb 4, 2009·Health Services Research·M Christopher Roebuck, Joshua N Liberman
Sep 3, 2008·Health Services Research·Dennis P ScanlonJon B Christianson
Mar 29, 2008·Health Services Research·Michael Chernew, A Mark Fendrick
Aug 3, 2011·Journal of the American Geriatrics Society·Jennifer M PolinskiWilliam H Shrank
Oct 5, 2011·California Journal of Politics and Policy·Arleen A Leibowitz, Katherine Desmond
Jun 22, 2011·Health Services Research·Virginia WangMatthew L Maciejewski
Dec 21, 2013·Health Services Research·Kyoungrae JungA Marshall McBean
Mar 11, 2015·Health Services Research·Matthew B FrankMichael E Chernew
Dec 11, 2014·Health Economics·David B Ridley
Nov 26, 2015·Preventing Chronic Disease·Gibril J NjieUNKNOWN Community Preventive Services Task Force

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.